- Home
- ENVB vs LGHL Comparison
ENVB vs LGHL Comparison
Compare ENVB & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- LGHL
- Stock Information
- Founded
- ENVB 1994
- LGHL 2015
- Country
- ENVB United States
- LGHL Singapore
- Employees
- ENVB N/A
- LGHL N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- LGHL Investment Bankers/Brokers/Service
- Sector
- ENVB Health Care
- LGHL Finance
- Exchange
- ENVB Nasdaq
- LGHL Nasdaq
- Market Cap
- ENVB 3.0M
- LGHL 3.3M
- IPO Year
- ENVB N/A
- LGHL N/A
- Fundamental
- Price
- ENVB $5.63
- LGHL $0.73
- Analyst Decision
- ENVB Strong Buy
- LGHL
- Analyst Count
- ENVB 1
- LGHL 0
- Target Price
- ENVB $120.00
- LGHL N/A
- AVG Volume (30 Days)
- ENVB 128.8K
- LGHL 109.3K
- Earning Date
- ENVB 11-14-2025
- LGHL 01-01-0001
- Dividend Yield
- ENVB N/A
- LGHL N/A
- EPS Growth
- ENVB N/A
- LGHL N/A
- EPS
- ENVB N/A
- LGHL N/A
- Revenue
- ENVB N/A
- LGHL N/A
- Revenue This Year
- ENVB N/A
- LGHL N/A
- Revenue Next Year
- ENVB N/A
- LGHL N/A
- P/E Ratio
- ENVB N/A
- LGHL N/A
- Revenue Growth
- ENVB N/A
- LGHL N/A
- 52 Week Low
- ENVB $4.88
- LGHL $0.68
- 52 Week High
- ENVB $96.30
- LGHL $16.40
- Technical
- Relative Strength Index (RSI)
- ENVB 59.55
- LGHL 35.49
- Support Level
- ENVB $4.88
- LGHL $0.77
- Resistance Level
- ENVB $6.10
- LGHL $0.93
- Average True Range (ATR)
- ENVB 0.90
- LGHL 0.09
- MACD
- ENVB -0.19
- LGHL 0.01
- Stochastic Oscillator
- ENVB 20.64
- LGHL 18.27
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.